Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 2,090.00
-65.00 (-3.02%)
Aug 12, 2026, 12:06 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 50.73 billion as of August 11, 2026. Its market cap has decreased by -58.85% in one year.
Market Cap
50.73B
Enterprise Value
296.94B
Revenue
78.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,090.00
ChartMarket Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 50.73B, an increase of 1,496.53%. That is a compound annual growth rate of 9.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 49.90B | -51.33% |
| Dec 30, 2025 | 102.54B | -21.60% |
| Dec 30, 2024 | 130.79B | -31.41% |
| Dec 28, 2023 | 190.68B | -4.89% |
| Dec 29, 2022 | 200.48B | -44.42% |
| Dec 30, 2021 | 360.71B | -31.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SAMSUNG PHARM. Co., LTD. | 126.22B |
| HANDOK | 123.80B |
| HLB Pharmaceutical | 122.73B |
| Jeil Pharma Holdings | 115.44B |
| CMG Pharmaceutical | 104.28B |
| CKD Bio | 79.22B |
| Enzychem Lifesciences | 76.86B |
| Ildong Holdings | 74.75B |